Fresenius Medical Care AG & Co. KGaA (FME) Receives €88.39 Consensus Price Target from Brokerages

Shares of Fresenius Medical Care AG & Co. KGaA (ETR:FME) have been assigned a consensus rating of “Hold” from the twenty research firms that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and ten have issued a buy rating on the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is €88.39 ($105.22).

A number of equities analysts have recently commented on FME shares. J P Morgan Chase & Co set a €106.40 ($126.67) target price on Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a report on Tuesday, June 13th. Citigroup Inc. set a €92.00 ($109.52) price objective on Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a report on Friday, June 9th. Berenberg Bank set a €95.00 ($113.10) price objective on Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a report on Friday, June 30th. UBS AG set a €68.00 ($80.95) target price on Fresenius Medical Care AG & Co. KGaA and gave the stock a “sell” rating in a report on Friday, July 14th. Finally, Deutsche Bank AG set a €84.00 ($100.00) target price on Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a report on Tuesday, August 8th.

ILLEGAL ACTIVITY NOTICE: “Fresenius Medical Care AG & Co. KGaA (FME) Receives €88.39 Consensus Price Target from Brokerages” was posted by Ticker Report and is owned by of Ticker Report. If you are viewing this report on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The original version of this report can be accessed at https://www.tickerreport.com/banking-finance/2887238/fresenius-medical-care-ag-88-39-consensus-price-target-from-brokerages.html.

Shares of Fresenius Medical Care AG & Co. KGaA (ETR:FME) traded up 0.444% during midday trading on Friday, hitting €81.001. The stock had a trading volume of 1,074 shares. Fresenius Medical Care AG & Co. KGaA has a 12 month low of €70.82 and a 12 month high of €89.07. The firm has a market cap of €24.86 billion and a price-to-earnings ratio of 20.887. The stock’s 50 day moving average price is €79.21 and its 200 day moving average price is €81.55.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.